Halozyme Therapeutics Inc. buy geldnutzer
Start price
16.09.24
/
70%
€56.30
Target price
16.09.25
€62.00
Performance (%)
-1.03%
Price
17.09.24
€55.72
Summary
This prediction is currently active. With a performance of -1.03%, the BUY prediction for Halozyme Therapeutics Inc. by geldnutzer is down slightly. This prediction currently runs until 16.09.25. The prediction end date can be changed by geldnutzer at any time. geldnutzer has 70% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Halozyme Therapeutics Inc. | -1.03% |
| iShares Core DAX® | 1.887% |
| iShares Nasdaq 100 | 2.316% |
| iShares Nikkei 225® | 1.134% |
| iShares S&P 500 | 1.821% |
According to geldnutzer what are the pros and cons of Halozyme Therapeutics Inc. for the foreseeable future?
Pros
Revenue growth >5% per year expected
Some uniques
Sustainability is important
Medium risks for its business
Future proof or reliable business model
Fair valuation
ROE higher than 10% per year
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Good rating
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Cons
Low dividend yield expected
Dependend from some customers or products
Growths slower than the competition
Significant cyclical dependencies
Little known brand
high free float
negative Cash Flow expected
Below average Marketposition